Outcome of CDV therapy
| Indication for therapy . | No. treated . | Response (%) . |
|---|---|---|
| CMV pneumonia | 16 | 9/16 (56) |
| Other CMV disease | 4 | 1/4 (25) |
| Secondary preemptive therapy | 38 | 26/38 (68) |
| Failure | 20 | 11/20 (55) |
| Relapse | 18 | 15/18 (83) |
| Primary preemptive therapy | 26 | 15/26 (58) |
| Indication for therapy . | No. treated . | Response (%) . |
|---|---|---|
| CMV pneumonia | 16 | 9/16 (56) |
| Other CMV disease | 4 | 1/4 (25) |
| Secondary preemptive therapy | 38 | 26/38 (68) |
| Failure | 20 | 11/20 (55) |
| Relapse | 18 | 15/18 (83) |
| Primary preemptive therapy | 26 | 15/26 (58) |
CMV indicates cytomegalovirus.